Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps

NCT04534348 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 598

Last updated 2025-04-06

No results posted yet for this study

Summary

Observational study on the reduction of catheter-related Infections by use of self-disinfecting venous and arterial access caps (Curos caps ;3M, Saint Paul, MN, USA)

Conditions

  • CLABSI - Central Line Associated Bloodstream Infection
  • Catheter-Related Blood Stream Infection

Interventions

DEVICE

70% isopropyl alcohol-impregnated catheter caps

Implementation of 70% isopropyl alcohol-impregnated catheter caps in order to assess the number of CLABSI diagnosed during 1 Year

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-12-31
Completion
2020-01-31
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04534348 on ClinicalTrials.gov